![](https://webarchive.library.unt.edu/eot2008/20090118123633im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |
Prescription and Over-the-Counter Drug Product List
28th Edition
Cumulative Supplement Number 11: November 2008
NOTE: The format for the Monthly Additions/Deletions Drug
Product List changed as of the July Cumulative Supplement (CS) of the 21st
Edition to mirror the CS. Refer to the CS Preface section 1.6
Cumulative Supplement Legend. ![PDF](https://webarchive.library.unt.edu/eot2008/20090118123633im_/http://www.fda.gov/cder/graphics/pdf.gif)
ACETAMINOPHEN; BUTALBITAL; CAFFEINE
TABLET; ORAL
BUTALBITAL ACETAMINOPHEN AND CAFFEINE
>A> AB CONCORD LABS NJ 325MG;50MG;40MG N40864 001 Dec 01, 2008 Nov NEWA
ACETAMINOPHEN; CODEINE PHOSPHATE
TABLET; ORAL
CODRIX
>D> @ ANDRX PHARMS 500MG;30MG N40441 001 Mar 27, 2003 Nov CAHN
>A> @ WATSON LABS 500MG;30MG N40441 001 Mar 27, 2003 Nov CAHN
ACETAMINOPHEN; PROPOXYPHENE NAPSYLATE
TABLET; ORAL
PROPOXYPHENE NAPSYLATE AND ACETAMINOPHEN
>D> AB ANDRX PHARMS 500MG;100MG N77196 001 Jun 28, 2005 Nov CAHN
>A> AB WATSON LABS 500MG;100MG N77196 001 Jun 28, 2005 Nov CAHN
ACETAZOLAMIDE
CAPSULE, EXTENDED RELEASE; ORAL
>A> ACETAZOLAMIDE
>A> AB ZYDUS PHARMS 500MG N40904 001 Dec 10, 2008 Nov NEWA
DIAMOX
>D> + DURAMED PHARMS 500MG N12945 001 Nov CFTG
>A> AB + 500MG N12945 001 Nov CFTG
ACETAZOLAMIDE SODIUM
INJECTABLE; INJECTION
ACETAZOLAMIDE SODIUM
>A> AP X GEN PHARMS EQ 500MG BASE/VIAL N40784 001 Dec 10, 2008 Nov NEWA
ALBUTEROL SULFATE
SOLUTION; INHALATION
ALBUTEROL SULFATE
>A> AN LANNETT EQ 0.083% BASE N77839 001 Dec 16, 2008 Nov NEWA
ALPRAZOLAM
TABLET; ORAL
ALPRAZOLAM
>A> AB VINTAGE 2MG N78491 004 Dec 12, 2008 Nov NEWA
AMOXICILLIN; CLAVULANATE POTASSIUM
FOR SUSPENSION; ORAL
>A> AMOXICILLIN AND CLAVULANATE POTASSIUM
>A> AB MORTON GROVE 250MG/5ML;EQ 62.5MG BASE/5ML N65431 001 Nov 25, 2008 Nov NEWA
AUGMENTIN '250'
>D> + GLAXOSMITHKLINE 250MG/5ML;EQ 62.5MG BASE/5ML N50575 002 Aug 06, 1984 Nov CFTG
>A> AB + 250MG/5ML;EQ 62.5MG BASE/5ML N50575 002 Aug 06, 1984 Nov CFTG
AMPICILLIN/AMPICILLIN TRIHYDRATE
FOR SUSPENSION; ORAL
AMPICILLIN TRIHYDRATE
>D> AB CLONMEL EQ 250MG BASE/5ML N62982 002 Feb 10, 1989 Nov CRLD
>A> + EQ 250MG BASE/5ML N62982 002 Feb 10, 1989 Nov CRLD
ARGATROBAN
INJECTABLE; INJECTION
ARGATROBAN
>D> + ENCYSIVE 100MG/ML N20883 001 Jun 30, 2000 Nov CAHN
>A> + PFIZER 100MG/ML N20883 001 Jun 30, 2000 Nov CAHN
BETAMETHASONE VALERATE
CREAM; TOPICAL
BETAMETHASONE VALERATE
>D> AB TARO EQ 0.1% BASE N70062 001 May 14, 1985 Nov DISC
>A> @ EQ 0.1% BASE N70062 001 May 14, 1985 Nov DISC
LOTION; TOPICAL
BETAMETHASONE VALERATE
>D> AB ACTAVIS MID EQ 0.1% BASE N70052 001 Jul 31, 1985 Nov CAHN
>A> AB STAT-TRADE EQ 0.1% BASE N70052 001 Jul 31, 1985 Nov CAHN
BUDESONIDE
SUSPENSION; INHALATION
>A> BUDESONIDE
>A> AN IVAX PHARMS INC 0.25MG/2ML N77519 001 Nov 18, 2008 Nov NEWA
>A> AN 0.5MG/2ML N77519 002 Nov 18, 2008 Nov NEWA
PULMICORT RESPULES
>D> ASTRAZENECA 0.25MG/2ML N20929 001 Aug 08, 2000 Nov CFTG
>A> AN 0.25MG/2ML N20929 001 Aug 08, 2000 Nov CFTG
>D> 0.5MG/2ML N20929 002 Aug 08, 2000 Nov CFTG
>A> AN 0.5MG/2ML N20929 002 Aug 08, 2000 Nov CFTG
BUPROPION HYDROCHLORIDE
TABLET, EXTENDED RELEASE; ORAL
BUPROPION HYDROCHLORIDE
>A> AB3 ACTAVIS 150MG N77285 001 Nov 26, 2008 Nov NEWA
>A> AB3 IMPAX LABS 150MG N77415 001 Nov 26, 2008 Nov NEWA
>A> AB3 WATSON LABS 150MG N77715 001 Nov 26, 2008 Nov NEWA
CALCIUM ACETATE
TABLET; ORAL
ELIPHOS
>A> + CYPRESS PHARM EQ 169MG CALCIUM N78502 001 Nov 25, 2008 Nov NEWA
CARBOPLATIN
INJECTABLE; IV (INFUSION)
CARBOPLATIN
>A> AP PLIVA LACHEMA EQ 50MG/5ML (10MG/ML) N78631 001 Dec 02, 2008 Nov NEWA
>A> AP EQ 150MG/15ML (10MG/ML) N78631 002 Dec 02, 2008 Nov NEWA
>A> AP EQ 450MG/45ML (10MG/ML) N78631 003 Dec 02, 2008 Nov NEWA
>A> AP EQ 600MG/60ML (10MG/ML) N78631 004 Dec 02, 2008 Nov NEWA
CETIRIZINE HYDROCHLORIDE
SYRUP; ORAL
>D> CERTIRIZINE HYDROCHLORIDE
>D> AA TEVA PHARMS 5MG/5ML N77279 001 May 27, 2008 Nov CTNA
>A> CETIRIZINE HYDROCHLORIDE
>A> AA TEVA PHARMS 5MG/5ML N77279 001 May 27, 2008 Nov CTNA
CEVIMELINE HYDROCHLORIDE
CAPSULE; ORAL
EVOXAC
>D> + DAIICHI EQ 30MG BASE N20989 002 Jan 11, 2000 Nov CAHN
>A> + DAIICHI SANKYO CO EQ 30MG BASE N20989 002 Jan 11, 2000 Nov CAHN
CIPROFLOXACIN HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC
CIPROFLOXACIN HYDROCHLORIDE
>A> AT AKORN INC EQ 0.3% BASE N76555 001 Dec 11, 2008 Nov NEWA
CITALOPRAM HYDROBROMIDE
TABLET; ORAL
CITALOPRAM HYDROBROMIDE
>D> AB TARO EQ 10MG BASE N77278 001 Mar 22, 2006 Nov DISC
>A> @ EQ 10MG BASE N77278 001 Mar 22, 2006 Nov DISC
>D> AB EQ 20MG BASE N77278 002 Mar 22, 2006 Nov DISC
>A> @ EQ 20MG BASE N77278 002 Mar 22, 2006 Nov DISC
>D> AB EQ 40MG BASE N77278 003 Mar 22, 2006 Nov DISC
>A> @ EQ 40MG BASE N77278 003 Mar 22, 2006 Nov DISC
CLOBETASOL PROPIONATE
LOTION; TOPICAL
>A> CLOBETASOL PROPIONATE
>A> AB ACTAVIS MID 0.05% N78223 001 Dec 04, 2008 Nov NEWA
CLOBEX
>D> + GALDERMA LABS LP 0.05% N21535 001 Jul 24, 2003 Nov CFTG
>A> AB + 0.05% N21535 001 Jul 24, 2003 Nov CFTG
CODEINE PHOSPHATE; PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE
SYRUP; ORAL
TRIACIN-C
>D> + ACTAVIS MID 10MG/5ML;30MG/5ML;1.25MG/5ML N88704 001 Mar 22, 1985 Nov CAHN
>A> + STAT-TRADE 10MG/5ML;30MG/5ML;1.25MG/5ML N88704 001 Mar 22, 1985 Nov CAHN
DEMECLOCYCLINE HYDROCHLORIDE
TABLET; ORAL
DEMECLOCYCLINE HYDROCHLORIDE
>A> AB COVENANT 150MG N65389 001 Dec 01, 2008 Nov NEWA
>A> AB 300MG N65389 002 Dec 01, 2008 Nov NEWA
DEXAMETHASONE
ELIXIR; ORAL
DEXAMETHASONE
>D> AA + ACTAVIS MID 0.5MG/5ML N84754 001 Nov CAHN
>A> AA + STAT-TRADE 0.5MG/5ML N84754 001 Nov CAHN
DIFLUNISAL
TABLET; ORAL
DIFLUNISAL
>D> AB TEVA 500MG N73673 001 Jul 31, 1992 Nov CRLD
>A> AB + 500MG N73673 001 Jul 31, 1992 Nov CRLD
DILTIAZEM HYDROCHLORIDE
INJECTABLE; INJECTION
DILTIAZEM HYDROCHLORIDE
>A> AP BAXTER HLTHCARE 5MG/ML N78538 001 Dec 17, 2008 Nov NEWA
DIVALPROEX SODIUM
TABLET, DELAYED RELEASE; ORAL
DIVALPROEX SODIUM
>A> AB ORCHID HLTHCARE EQ 125MG VALPROIC ACID N78853 001 Nov 25, 2008 Nov NEWA
>A> AB EQ 250MG VALPROIC ACID N78853 002 Nov 25, 2008 Nov NEWA
>A> AB EQ 500MG VALPROIC ACID N78853 003 Nov 25, 2008 Nov NEWA
DORZOLAMIDE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC
DORZOLAMIDE HYDROCHLORIDE
>A> AT TEVA PHARMS EQ 2% BASE N78756 001 Dec 04, 2008 Nov NEWA
ECHOTHIOPHATE IODIDE
FOR SOLUTION; OPHTHALMIC
PHOSPHOLINE IODIDE
>D> @ AYERST 0.03% N11963 002 Nov CAHN
>D> @ 0.06% N11963 004 Nov CAHN
>D> + 0.125% N11963 001 Nov CAHN
>D> @ 0.25% N11963 003 Nov CAHN
>A> @ WYETH PHARMS 0.03% N11963 002 Nov CAHN
>A> @ 0.06% N11963 004 Nov CAHN
>A> + 0.125% N11963 001 Nov CAHN
>A> @ 0.25% N11963 003 Nov CAHN
EDROPHONIUM CHLORIDE
INJECTABLE; INJECTION
ENLON
>D> @ BAXTER HLTHCARE 10MG/ML N88873 001 Aug 06, 1985 Nov CAHN
>A> @ BIONICHE PHARMA 10MG/ML N88873 001 Aug 06, 1985 Nov CAHN
>A> ELTROMBOPAG OLAMINE
>A> TABLET; ORAL
>A> PROMACTA
>A> GLAXOSMITHKLINE EQ 25MG ACID N22291 001 Nov 20, 2008 Nov NEWA
>A> + EQ 50MG ACID N22291 002 Nov 20, 2008 Nov NEWA
ERYTHROMYCIN
SOLUTION; TOPICAL
>D> A/T/S
>D> AT TARO PHARMS 2% N62405 001 Nov 18, 1982 Nov DISC
>A> @ 2% N62405 001 Nov 18, 1982 Nov DISC
ESTROGENS, CONJUGATED SYNTHETIC A
CREAM; VAGINAL
>A> SYNTHETIC CONJUGATED ESTROGENS A
>A> + DURAMED 0.625MG/GM N21788 001 Nov 28, 2008 Nov NEWA
ETHINYL ESTRADIOL; NORETHINDRONE
TABLET; ORAL-21
>D> BREVICON 21-DAY
>D> AB + WATSON LABS 0.035MG;0.5MG N17566 001 Nov DISC
>A> @ 0.035MG;0.5MG N17566 001 Nov DISC
NORETHINDRONE AND ETHINYL ESTRADIOL
>D> AB WATSON LABS 0.035MG;0.5MG N70684 001 Jan 29, 1987 Nov DISC
>A> @ 0.035MG;0.5MG N70684 001 Jan 29, 1987 Nov DISC
TABLET; ORAL-28
MODICON 28
>D> AB ORTHO MCNEIL 0.035MG;0.5MG N17735 001 Nov CRLD
>A> AB + 0.035MG;0.5MG N17735 001 Nov CRLD
ETODOLAC
TABLET, EXTENDED RELEASE; ORAL
ETODOLAC
>D> @ ANDRX PHARMS 400MG N75829 001 Nov 30, 2001 Nov CAHN
>D> @ 500MG N75829 002 Nov 30, 2001 Nov CAHN
>A> @ WATSON LABS 400MG N75829 001 Nov 30, 2001 Nov CAHN
>A> @ 500MG N75829 002 Nov 30, 2001 Nov CAHN
FINASTERIDE
TABLET; ORAL
FINASTERIDE
>D> AB IVAX PHARMS 5MG N76340 001 Jun 19, 2006 Nov DISC
>A> @ 5MG N76340 001 Jun 19, 2006 Nov DISC
GALANTAMINE HYDROBROMIDE
CAPSULE, EXTENDED RELEASE; ORAL
GALANTAMINE HYDROBROMIDE
>A> AB DANBURY PHARMA EQ 8MG BASE N79028 001 Dec 15, 2008 Nov NEWA
>A> AB EQ 16MG BASE N79028 002 Dec 15, 2008 Nov NEWA
>A> AB EQ 24MG BASE N79028 003 Dec 15, 2008 Nov NEWA
GEMCITABINE HYDROCHLORIDE
INJECTABLE; INJECTION
>A> GEMCITABINE HYDROCHLORIDE
>A> AP TEVA PARENTERAL EQ 200MG BASE/VIAL N77961 001 Dec 18, 2008 Nov NEWA
>A> AP EQ 1GM BASE/VIAL N77983 001 Dec 18, 2008 Nov NEWA
GEMZAR
>D> + LILLY EQ 200MG BASE/VIAL N20509 001 May 15, 1996 Nov CFTG
>A> AP + EQ 200MG BASE/VIAL N20509 001 May 15, 1996 Nov CFTG
>D> + EQ 1GM BASE/VIAL N20509 002 May 15, 1996 Nov CFTG
>A> AP + EQ 1GM BASE/VIAL N20509 002 May 15, 1996 Nov CFTG
HYDRALAZINE HYDROCHLORIDE
TABLET; ORAL
HYDRALAZINE HYDROCHLORIDE
>A> AA INVAGEN PHARMS 10MG N90255 001 Dec 15, 2008 Nov NEWA
>A> AA 25MG N90255 002 Dec 15, 2008 Nov NEWA
>A> AA 50MG N90255 003 Dec 15, 2008 Nov NEWA
>A> AA 100MG N90255 004 Dec 15, 2008 Nov NEWA
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
CAPSULE; ORAL
HYDRA-ZIDE
>D> AB PAR PHARM 25MG;25MG N88957 001 Oct 21, 1985 Nov CTEC
>A> 25MG;25MG N88957 001 Oct 21, 1985 Nov CTEC
>D> AB 50MG;50MG N88946 001 Oct 21, 1985 Nov CRLD
>A> + 50MG;50MG N88946 001 Oct 21, 1985 Nov CRLD
HYDROCODONE BITARTRATE; IBUPROFEN
TABLET; ORAL
REPREXAIN
>D> @ AMNEAL PHARMS 2.5MG;200MG N76642 003 Oct 19, 2007 Nov CMFD
>A> 2.5MG;200MG N76642 003 Oct 19, 2007 Nov CMFD
>D> @ 10MG;200MG N76642 004 Oct 19, 2007 Nov CMFD
>A> + 10MG;200MG N76642 004 Oct 19, 2007 Nov CMFD
IBUPROFEN
SUSPENSION; ORAL
MOTRIN
>A> AB + MCNEIL CONS 100MG/5ML N19842 001 Sep 19, 1989 Nov CAHN
>D> AB + MCNEIL PED 100MG/5ML N19842 001 Sep 19, 1989 Nov CAHN
TABLET; ORAL
IBUPROFEN
>D> AB MUTUAL PHARM 300MG N71230 001 Oct 22, 1986 Nov CAHN
>D> AB 400MG N71231 001 Oct 22, 1986 Nov CAHN
>D> AB 600MG N71232 001 Oct 22, 1986 Nov CAHN
>D> AB 800MG N72004 001 Nov 18, 1987 Nov CAHN
>A> AB VINTAGE PHARMS 300MG N71230 001 Oct 22, 1986 Nov CAHN
>A> AB 400MG N71231 001 Oct 22, 1986 Nov CAHN
>A> AB 600MG N71232 001 Oct 22, 1986 Nov CAHN
>A> AB 800MG N72004 001 Nov 18, 1987 Nov CAHN
MOTRIN
>A> MCNEIL CONS 300MG N17463 003 Nov DISC
>A> AB 400MG N17463 002 Nov CAHN
>A> AB 600MG N17463 004 Nov CAHN
>A> AB + 800MG N17463 005 May 22, 1985 Nov CAHN
>D> AB MCNEIL PED 300MG N17463 003 Nov DISC
>D> AB 400MG N17463 002 Nov CAHN
>D> AB 600MG N17463 004 Nov CAHN
>D> AB + 800MG N17463 005 May 22, 1985 Nov CAHN
>D> INSULIN ASPART PROTAMINE RECOMBINANT; INSULIN ASPART RECOMBINANT
>D> INJECTABLE; SUBCUTANEOUS
>D> NOVOLOG MIX 50/50
>D> + NOVO NORDISK INC 50 UNITS/ML;50 UNITS/ML N21810 001 Aug 26, 2008 Nov DISC
>A> @ 50 UNITS/ML;50 UNITS/ML N21810 001 Aug 26, 2008 Nov DISC
IOPROMIDE
INJECTABLE; INJECTION
ULTRAVIST 300 IN PLASTIC CONTAINER
>A> + BAYER HLTHCARE 62.3% N20220 005 Nov 18, 2008 Nov NEWA
IRINOTECAN HYDROCHLORIDE
INJECTABLE; INJECTION
IRINOTECAN HYDROCHLORIDE
>A> AP ACCORD 40MG/2ML (20MG/ML) N79068 001 Nov 21, 2008 Nov NEWA
>A> AP 100MG/5ML (20MG/ML) N79068 002 Nov 21, 2008 Nov NEWA
>A> AP TEVA PARENTERAL 500MG/25ML (20MG/ML) N90101 001 Nov 26, 2008 Nov NEWA
LACTULOSE
SOLUTION; ORAL, RECTAL
LACTULOSE
>A> AA ANI PHARMS INC 10GM/15ML N90426 001 Nov 21, 2008 Nov NEWA
LEVOTHYROXINE SODIUM**
TABLET; ORAL
NOVOTHYROX
>D> @ GENPHARM 0.025MG N21292 001 May 31, 2002 Nov CAHN
>D> @ 0.05MG N21292 002 May 31, 2002 Nov CAHN
>D> @ 0.075MG N21292 003 May 31, 2002 Nov CAHN
>D> @ 0.088MG N21292 004 May 31, 2002 Nov CAHN
>D> @ 0.1MG N21292 005 May 31, 2002 Nov CAHN
>D> @ 0.112MG N21292 006 May 31, 2002 Nov CAHN
>D> @ 0.125MG N21292 007 May 31, 2002 Nov CAHN
>D> @ 0.137MG N21292 008 May 31, 2002 Nov CAHN
>D> @ 0.15MG N21292 009 May 31, 2002 Nov CAHN
>D> @ 0.175MG N21292 010 May 31, 2002 Nov CAHN
>D> @ 0.2MG N21292 011 May 31, 2002 Nov CAHN
>D> @ 0.3MG N21292 012 May 31, 2002 Nov CAHN
>A> @ MERCK KGAA 0.025MG N21292 001 May 31, 2002 Nov CAHN
>A> @ 0.05MG N21292 002 May 31, 2002 Nov CAHN
>A> @ 0.075MG N21292 003 May 31, 2002 Nov CAHN
>A> @ 0.088MG N21292 004 May 31, 2002 Nov CAHN
>A> @ 0.1MG N21292 005 May 31, 2002 Nov CAHN
>A> @ 0.112MG N21292 006 May 31, 2002 Nov CAHN
>A> @ 0.125MG N21292 007 May 31, 2002 Nov CAHN
>A> @ 0.137MG N21292 008 May 31, 2002 Nov CAHN
>A> @ 0.15MG N21292 009 May 31, 2002 Nov CAHN
>A> @ 0.175MG N21292 010 May 31, 2002 Nov CAHN
>A> @ 0.2MG N21292 011 May 31, 2002 Nov CAHN
>A> @ 0.3MG N21292 012 May 31, 2002 Nov CAHN
METAPROTERENOL SULFATE
>D> AEROSOL, METERED; INHALATION
>D> ALUPENT
>D> + BOEHRINGER 0.65MG/INH N16402 001 Nov DISC
>A> @ 0.65MG/INH N16402 001 Nov DISC
SOLUTION; INHALATION
METAPROTERENOL SULFATE
>D> AN DEY 0.4% N71786 001 Aug 05, 1988 Nov CRLD
>A> AN + 0.4% N71786 001 Aug 05, 1988 Nov CRLD
>D> AN 0.6% N70804 001 Aug 17, 1987 Nov CRLD
>A> AN + 0.6% N70804 001 Aug 17, 1987 Nov CRLD
METFORMIN HYDROCHLORIDE
TABLET; ORAL
METFORMIN HYDROCHLORIDE
>A> AB INDICUS PHARMA 500MG N79148 001 Nov 25, 2008 Nov NEWA
>A> AB 850MG N79148 002 Nov 25, 2008 Nov NEWA
>A> AB 1GM N79148 003 Nov 25, 2008 Nov NEWA
METHYLERGONOVINE MALEATE
INJECTABLE; INJECTION
METHERGINE
>D> + NOVARTIS 0.2MG/ML N06035 004 Nov CFTG
>A> AP + 0.2MG/ML N06035 004 Nov CFTG
>A> METHYLERGONOVINE MALEATE
>A> AP PHARMAFORCE 0.2MG/ML N90193 001 Nov 24, 2008 Nov NEWA
METHYLPREDNISOLONE SODIUM SUCCINATE
INJECTABLE; INJECTION
A-METHAPRED
>A> AP HEMOPHARM USA EQ 40MG BASE/VIAL N40793 001 Nov 25, 2008 Nov NEWA
>A> AP EQ 125MG BASE/VIAL N40827 001 Nov 25, 2008 Nov NEWA
MIRTAZAPINE
TABLET; ORAL
MIRTAZAPINE
>D> AB IVAX PHARMS 15MG N76244 001 Dec 22, 2003 Nov DISC
>A> @ 15MG N76244 001 Dec 22, 2003 Nov DISC
>D> AB 30MG N76244 002 Dec 22, 2003 Nov DISC
>A> @ 30MG N76244 002 Dec 22, 2003 Nov DISC
>D> AB 45MG N76244 003 Dec 22, 2003 Nov DISC
>A> @ 45MG N76244 003 Dec 22, 2003 Nov DISC
NAPROXEN SODIUM
TABLET, EXTENDED RELEASE; ORAL
NAPRELAN
>D> @ STAT TRADE EQ 750MG BASE N20353 003 Jan 05, 1996 Nov CMFD
>A> EQ 750MG BASE N20353 003 Jan 05, 1996 Nov CMFD
NEDOCROMIL SODIUM
>D> AEROSOL, METERED; INHALATION
>D> TILADE
>D> + KING PHARMS 1.75MG/INH N19660 001 Dec 30, 1992 Nov DISC
>A> @ 1.75MG/INH N19660 001 Dec 30, 1992 Nov DISC
OFLOXACIN
SOLUTION/DROPS; OPHTHALMIC
OFLOXACIN
>A> AT SANDOZ 0.3% N76848 001 Nov 25, 2008 Nov NEWA
ONDANSETRON HYDROCHLORIDE
INJECTABLE; INJECTION
ONDANSETRON HYDROCHLORIDE
>A> AP LUITPOLD EQ 2MG BASE/ML N79039 001 Nov 18, 2008 Nov NEWA
>A> AP ONLUITPOLD REEQ 2MG BASE/ML N79032 001 Nov 18, 2008 Nov NEWA
PALONOSETRON HYDROCHLORIDE
INJECTABLE; INTRAVENOUS
ALOXI
>D> HELSINN HLTHCARE EQ 0.075MG BASE/1.5ML (EQ 0.05MG N21372 002 Feb 29, 2008 Nov CRLD
>A> + EQ 0.075MG BASE/1.5ML (EQ 0.05MG N21372 002 Feb 29, 2008 Nov CRLD
PAMIDRONATE DISODIUM
INJECTABLE; INJECTION
PAMIDRONATE DISODIUM
>A> AP CIPLA LTD 30MG/VIAL N77433 001 Nov 26, 2008 Nov NEWA
>A> AP 60MG/VIAL N77433 002 Nov 26, 2008 Nov NEWA
>A> AP 90MG/VIAL N77433 003 Nov 26, 2008 Nov NEWA
PAROXETINE HYDROCHLORIDE
TABLET; ORAL
PAROXETINE HYDROCHLORIDE
>A> AB APOTEX EQ 10MG BASE N75356 001 Jul 30, 2003 Nov CAHN
>A> AB EQ 20MG BASE N75356 002 Jul 30, 2003 Nov CAHN
>A> AB EQ 30MG BASE N75356 003 Jul 30, 2003 Nov CAHN
>A> AB EQ 40MG BASE N75356 004 Jul 30, 2003 Nov CAHN
>D> AB TORPHARM EQ 10MG BASE N75356 001 Jul 30, 2003 Nov CAHN
>D> AB EQ 20MG BASE N75356 002 Jul 30, 2003 Nov CAHN
>D> AB EQ 30MG BASE N75356 003 Jul 30, 2003 Nov CAHN
>D> AB EQ 40MG BASE N75356 004 Jul 30, 2003 Nov CAHN
POTASSIUM CHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
POTASSIUM CHLORIDE
>D> AB ANDRX PHARMS 8MEQ N77419 001 Jun 02, 2008 Nov CAHN
>D> AB 10MEQ N77419 002 Jun 02, 2008 Nov CAHN
>A> AB WATSON LABS 8MEQ N77419 001 Jun 02, 2008 Nov CAHN
>A> AB 10MEQ N77419 002 Jun 02, 2008 Nov CAHN
RANITIDINE HYDROCHLORIDE
TABLET; ORAL
RANITIDINE HYDROCHLORIDE
>A> AB GLENMARK EQ 150MG BASE N78542 001 Nov 19, 2008 Nov NEWA
>A> AB EQ 300MG BASE N78542 002 Nov 19, 2008 Nov NEWA
RISPERIDONE
TABLET; ORAL
RISPERIDONE
>A> AB COBALT LABS INC 0.25MG N77860 001 Dec 05, 2008 Nov NEWA
>A> AB 0.5MG N77860 002 Dec 05, 2008 Nov NEWA
>A> AB 1MG N77860 003 Dec 05, 2008 Nov NEWA
>A> AB 2MG N77860 004 Dec 05, 2008 Nov NEWA
>A> AB 3MG N77860 005 Dec 05, 2008 Nov NEWA
>A> AB 4MG N77860 006 Dec 05, 2008 Nov NEWA
ROCURONIUM BROMIDE
INJECTABLE; INJECTION
>A> ROCURONIUM BROMIDE
>A> AP GENERAMEDIX 50MG/5ML(10MG/ML) N79199 001 Nov 26, 2008 Nov NEWA
>A> AP 100MG/10ML(10MG/ML) N79199 002 Nov 26, 2008 Nov NEWA
>A> AP HOSPIRA 50MG/5ML(10MG/ML) N78519 001 Nov 26, 2008 Nov NEWA
>A> AP 100MG/10ML(10MG/ML) N78519 002 Nov 26, 2008 Nov NEWA
>A> AP SANDOZ 50MG/5ML (10MG/ML) N79195 001 Dec 05, 2008 Nov NEWA
>A> AP 100MG/10ML (10MG/ML) N79195 002 Dec 05, 2008 Nov NEWA
>A> AP TEVA PARENTERAL 50MG/5ML(10MG/ML) N78717 001 Nov 26, 2008 Nov NEWA
>A> AP 100MG/ML(10MG/ML) N78717 002 Nov 26, 2008 Nov NEWA
ZEMURON
>D> + ORGANON USA INC 50MG/5ML(10MG/ML) N20214 001 Mar 17, 1994 Nov CFTG
>A> AP + 50MG/5ML(10MG/ML) N20214 001 Mar 17, 1994 Nov CFTG
>D> + 100MG/10ML(10MG/ML) N20214 003 Mar 17, 1994 Nov CFTG
>A> AP + 100MG/10ML(10MG/ML) N20214 003 Mar 17, 1994 Nov CFTG
RUFINAMIDE
TABLET; ORAL
BANZEL
>A> @ EISAI MEDCL RES 100MG N21911 001 Nov 14, 2008 Nov DISC
>A> 200MG N21911 002 Nov 14, 2008 Nov NEWA
>A> + 400MG N21911 003 Nov 14, 2008 Nov NEWA
SODIUM POLYSTYRENE SULFONATE
POWDER; ORAL, RECTAL
SODIUM POLYSTYRENE SULFONATE
>A> AA NOVEL LABS INC 454GM/BOT N40909 001 Dec 03, 2008 Nov NEWA
SULFACETAMIDE SODIUM
SOLUTION/DROPS; OPHTHALMIC
BLEPH-30
>D> AT + ALLERGAN 30% N80028 002 Nov DISC
>A> @ 30% N80028 002 Nov DISC
SULINDAC
TABLET; ORAL
SULINDAC
>A> @ EPIC PHARMA 150MG N72710 001 Mar 25, 1991 Nov CAHN
>A> @ 200MG N72711 001 Mar 25, 1991 Nov CAHN
>D> @ WARNER CHILCOTT 150MG N72710 001 Mar 25, 1991 Nov CAHN
>D> @ 200MG N72711 001 Mar 25, 1991 Nov CAHN
>A> TAPENTADOL HYDROCHLORIDE
>A> TABLET; ORAL
>A> TAPENTADOL HYDROCHLORIDE
>A> ORTHO MCNEIL 50MG N22304 001 Nov 20, 2008 Nov NEWA
>A> 75MG N22304 002 Nov 20, 2008 Nov NEWA
>A> + 100MG N22304 003 Nov 20, 2008 Nov NEWA
>D> TETRACYCLINE PHOSPHATE COMPLEX
>D> CAPSULE; ORAL
>D> TETREX
>D> BRISTOL EQ 100MG HCL N61653 001 Nov DISC
>A> @ EQ 100MG HCL N61653 001 Nov DISC
>D> EQ 250MG HCL N61889 002 Nov DISC
>A> @ EQ 250MG HCL N61889 002 Nov DISC
>D> EQ 250MG HCL N61653 002 Nov DISC
>A> @ EQ 250MG HCL N61653 002 Nov DISC
>D> EQ 500MG HCL N61889 001 Nov DISC
>A> @ EQ 500MG HCL N61889 001 Nov DISC
URSODIOL
CAPSULE; ORAL
URSODIOL
>A> AB LANNETT 300MG N79082 001 Dec 15, 2008 Nov NEWA
ZALEPLON
CAPSULE; ORAL
ZALEPLON
>A> AB WEST WARD 5MG N78147 001 Nov 25, 2008 Nov NEWA
>A> AB 10MG N78147 002 Nov 25, 2008 Nov NEWA
ZOLPIDEM TARTRATE
TABLET; ORAL
ZOLPIDEM TARTRATE
>A> AB VINTAGE 5MG N78616 001 Nov 21, 2008 Nov NEWA
>A> AB 10MG N78616 002 Nov 21, 2008 Nov NEWA
IBUPROFEN
TABLET; ORAL
IBUPROFEN
>D> MUTUAL PHARM 200MG N72249 001 Jan 10, 1989 Nov CAHN
>D> 200MG N71229 001 Apr 01, 1987 Nov CAHN
>A> VINTAGE PHARMS 200MG N72249 001 Jan 10, 1989 Nov CAHN
>A> 200MG N71229 001 Apr 01, 1987 Nov CAHN
LORATADINE; PSEUDOEPHEDRINE SULFATE
TABLET, EXTENDED RELEASE; ORAL
LORATADINE AND PSEUDOEPHEDRINE SULFATE
>D> ANDRX PHARMS 5MG;120MG N76208 001 Jan 28, 2004 Nov CAHN
>A> WATSON LABS 5MG;120MG N76208 001 Jan 28, 2004 Nov CAHN
NAPROXEN SODIUM
TABLET; ORAL
NAPROXEN SODIUM
>A> AMNEAL PHARMS EQ 200MG BASE N79096 001 Dec 16, 2008 Nov NEWA
NONOXYNOL-9
SPONGE; VAGINAL
TODAY
>D> + ALLENDALE 1GM N18683 001 Apr 01, 1983 Nov CAHN
>A> + PAV NOVA 1GM N18683 001 Apr 01, 1983 Nov CAHN
Back
to Top
Back to Additions/Deletions Index
Date created: Decmeber 22, 2008 |
![](https://webarchive.library.unt.edu/eot2008/20090118123633im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |